ER Stress in COVID-19 and Parkinson’s Disease: In Vitro and In Silico Evidences
The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) signifies a serious worldwide concern to public health. Both transcriptome and proteome of SARS-CoV-2-infected cells synergize the progression of infection in host, which may exacerbate symptoms and/or pr...
Main Authors: | Zahara L. Chaudhry, Mahmoud Gamal, Ingrid Ferhati, Mohamad Warda, Bushra Y. Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/4/507 |
Similar Items
-
PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts
by: Giuseppina Amodio, et al.
Published: (2019-06-01) -
The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis
by: Yizhi Mao, et al.
Published: (2022-11-01) -
ER-Phagy and Its Role in ER Homeostasis in Plants
by: Yan Bao, et al.
Published: (2020-12-01) -
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
by: Camilla Scarpellini, et al.
Published: (2023-04-01) -
An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer
by: Claire M. Robinson, et al.
Published: (2021-01-01)